FdaApplication
ANDA 219464
Identifiers
- fda_app_no: ANDA219464
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMAZONE |
| application_type | ANDA |
| approval_date | 2026-06-30 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EVEROLIMUS | EVEROLIMUS | 0.5MG | TABLET;ORAL |
| EVEROLIMUS | EVEROLIMUS | 0.25MG | TABLET;ORAL |
| EVEROLIMUS | EVEROLIMUS | 1MG | TABLET;ORAL |
| EVEROLIMUS | EVEROLIMUS | 0.75MG | TABLET;ORAL |
4 products